GLIMITERIS M1 (Glimepiride & Metformin Hydrochloride Prolonged Release): explore.....

 GLIMITERIS M1 

Glimepiride & Metformin Hydrochloride Prolonged Release

GLIMITERIS M1 is a combination medication designed to manage type 2 diabetes mellitus effectively. It combines three active ingredients: Voglibose 0.2 mg, Glimepiride, and Metformin Hydrochloride Prolonged Release. This combination offers a comprehensive approach to controlling blood sugar levels by addressing different aspects of glucose metabolism. Each component plays a crucial role in ensuring optimal glycemic control, reducing the risk of diabetes-related complications, and improving the overall quality of life for patients with type 2 diabetes.

Uses

Voglibose 0.2 mg

Voglibose is an alpha-glucosidase inhibitor that helps in managing postprandial (after-meal) blood glucose spikes. It works by delaying the absorption of carbohydrates in the small intestine, thus preventing sudden increases in blood sugar levels after meals. This mechanism is particularly useful for controlling postprandial hyperglycemia, which is a common issue in diabetes management.

Glimepiride

Glimepiride belongs to the class of sulfonylureas and works by stimulating the release of insulin from the pancreatic beta cells. This helps in lowering blood sugar levels effectively. Glimepiride is known for its long-lasting effects and is often prescribed to enhance the body’s natural insulin production. It is particularly effective in reducing fasting blood sugar levels and HbA1c (glycated hemoglobin) levels.

Metformin Hydrochloride Prolonged Release

Metformin is a first-line medication for type 2 diabetes and is well-known for its efficacy and safety profile. The prolonged-release formulation ensures a steady release of the drug over an extended period, enhancing its effectiveness and minimizing gastrointestinal side effects. Metformin works by reducing hepatic glucose production, improving insulin sensitivity, and enhancing peripheral glucose uptake.

Dosage

General Dosage Guidelines

• Adults: The typical starting dose of GLIMITERIS M1 is one tablet daily, administered with meals to reduce the risk of gastrointestinal side effects.
• Adjustments: Dosage adjustments should be made based on the patient’s response to therapy, blood glucose levels, and tolerance.
• Monitoring: Regular monitoring of blood glucose levels is essential to assess the effectiveness of the treatment and make necessary adjustments.

Administration Tips

• Consistency: Take GLIMITERIS M1 at the same time each day to maintain consistent blood levels.
• Food: Administer with food to enhance absorption and minimize gastrointestinal discomfort.
• Hydration: Ensure adequate hydration while taking this medication to support metabolic processes.

Side Effects

Common Side Effects

• Gastrointestinal Issues: Nausea, vomiting, diarrhea, and abdominal discomfort are common, especially when starting the treatment.
• Hypoglycemia: Due to the presence of Glimepiride, there is a risk of low blood sugar levels, which can manifest as dizziness, sweating, confusion, and palpitations.
• Flatulence: Voglibose may cause increased gas production and bloating.

Serious Side Effects

• Lactic Acidosis: A rare but serious side effect associated with Metformin, characterized by muscle pain, difficulty breathing, abdominal pain, and irregular heartbeat. Immediate medical attention is required if symptoms occur.
• Allergic Reactions: Rash, itching, swelling, and difficulty breathing indicate a potential allergic reaction that needs prompt medical intervention.
• Severe Hypoglycemia: In cases of severe low blood sugar, symptoms such as seizures, loss of consciousness, or extreme weakness may occur. Emergency treatment is necessary.

Price

GLIMITERIS M1 is priced competitively to ensure affordability for patients requiring long-term diabetes management. The cost may vary depending on the pharmacy and the location. It is recommended to check with local pharmacies or online platforms for the most accurate pricing.

Conclusion

GLIMITERIS M1 offers a potent combination of Voglibose, Glimepiride, and Metformin Hydrochloride Prolonged Release, making it an effective solution for managing type 2 diabetes mellitus. By addressing multiple pathways involved in glucose metabolism, it helps in achieving optimal glycemic control and reducing the risk of complications associated with diabetes. Patients should adhere to the prescribed dosage, monitor their blood sugar levels regularly, and consult their healthcare provider for any concerns or adjustments in their treatment regimen. With consistent use and proper management, GLIMITERIS M1 can significantly improve the quality of life for individuals living with type 2 diabetes. Steris Healthcare Pvt Ltd, operating as Sterispharma since its founding by expert professionals in the pharmaceutical industry in February 2018, is based in Navi Mumbai. The company is certified by WHO, GMP, and ISO, emphasizing its commitment to quality and safety. Sterispharma focuses on providing high-quality drugs at affordable prices throughout India, adhering strictly to WHO guidelines. Offering the convenience of an online pharmacy, customers can easily purchase medicines with home delivery options available. Sterispharma's mission is to supply a broad range of healthcare products to meet the diverse needs of the medical community. From advanced treatments and medications for rare conditions to essential health necessities, Sterispharma aims to serve the extensive demands of the healthcare industry. You can order medicines from Sterispharma through their websites, sterisonline and sterispharma. Their extensive product lineup includes treatments for Cardiology, Asthma, Respiratory Issues, Nasal Conditions, Diabetes, Endocrinology, Gastroenterology, Orthopedics, Anti-infectives/Antibiotics, General Medicine, Urology, Neurology, Nephrology, Oncology, Gynecology, Pediatrics, Dental Care, and Dermatology.

For further information 

Email: info@sterispharma.com /  contact@sterispharma.com

Call/WhatsApp:  7877551268, 7849827488 

BUY NOW